Evaluating the evidence from clinical trials in chronic hepatitis C

Journal of Viral Hepatitis
R S Brown

Abstract

A number of studies are being published on investigational agents for the treatment of patients with chronic hepatitis C. Before incorporating new medications into therapy or electing to postpone therapy until an investigational agent receives regulatory approval, it is important to evaluate the following specific features of the published evidence: quality of the evidence, precision of the treatment effect, magnitude of the treatment effect, magnitude of the hazards, and other factors such as risk-benefit analysis and cost, including cost-effectiveness. Previous studies of treatment of patients with the disease allow us to establish some benchmarks and provide structure to evaluate the evidence of the efficacy and safety of these newer drugs.

References

Nov 30, 1989·The New England Journal of Medicine·G L DavisUNKNOWN Hepatitis Interventional Therapy Group
Nov 30, 1989·The New England Journal of Medicine·A M Di BisceglieJ H Hoofnagle
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Dec 15, 1995·Annals of Internal Medicine·A M Di BisceglieJ H Hoofnagle
Aug 19, 1995·BMJ : British Medical Journal·D G Altman, J M Bland
Aug 28, 1996·JAMA : the Journal of the American Medical Association·C BeggD F Stroup
Aug 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H C BodenheimerL B Seeff
Aug 13, 1998·Critical Care Clinics·G S Doig
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Z Younossi, G Guyatt
Jun 10, 2000·Journal of Viral Hepatitis·L A KondiliA Mele
Aug 19, 2000·Hematology/oncology Clinics of North America·S H Woolf, J N George
Apr 20, 2001·JAMA : the Journal of the American Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards of Reporting Trials)
Nov 6, 2001·Annals of Internal Medicine·L S PhillipsC S Barnes
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 3, 2002·Gastroenterology·John G McHutchisonUNKNOWN International Hepatitis Interventional Therapy Group
Feb 28, 2004·BMJ : British Medical Journal·Phil Alderson
Apr 30, 2004·The Medical Journal of Australia·R John SimesAnthony C Keech
Aug 18, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Alexandra BarrattUNKNOWN Evidence-Based Medicine Teaching Tips Working Group
Sep 16, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Victor M MontoriUNKNOWN Evidence-Based Medicine Teaching Tips Working Group
Sep 9, 2005·Critical Care Medicine·Marcus J Schultz
Nov 19, 2005·The Journal of Antimicrobial Chemotherapy·Robert G Gish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John H Powers
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
B E KatzW P Coleman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Joshua P SchillingArif Khan
© 2022 Meta ULC. All rights reserved